Optiflux
Payments companies reported to CMS as associated with Optiflux. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Optiflux, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Optiflux
These are the largest totals companies reported as associated with Optiflux. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Taryn Turner | Granbury, TX | Nephrology (Internal Medicine) | $169.24 |
| Anand Reddy | Odessa, TX | Nephrology (Internal Medicine) | $155.03 |
| Tiffany Vaught | Odessa, TX | Family | $155.02 |
| Joshua Lowentritt | New Orleans, LA | Nephrology (Internal Medicine) | $147.26 |
| Jeffrey Goodman | Florham Park, NJ | Nephrology (Internal Medicine) | $118.43 |
| Thomas Watson | Birmingham, AL | Nephrology (Internal Medicine) | $118.43 |
| Marc Brazie | Clinton, MD | Nephrology (Internal Medicine) | $118.43 |
| Andrew O Connor | Monroe, NC | Nephrology (Internal Medicine) | $118.43 |
| John Ducker | Fort Wayne, IN | Nephrology (Internal Medicine) | $118.42 |
| Naing Kyaw | Oceanside, CA | Nephrology (Internal Medicine) | $118.42 |
Prescribed Optiflux?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.